Skip to main content

NoDraw AI Agent

Bloodless blood diagnostics from a smartphone scan

NoDraw captures optical signals from the eye and skin, infers core blood markers, and returns confidence-scored outputs for clinical workflows.

Covers hemoglobin, RBC count, WBC count, hematocrit, platelet count, MCV, and MCH for continuous monitoring across anemia, metabolic, liver, and cardiorenal pathways.

Book PilotSee Platform

Live NoDraw app

Capture studio with real-time quality gating.

NoDraw app capture studio showing an eye scan with QC HUD and glare warning.
Select capture typeQuality gate HUDRole-aware routing

Technology workflow

Step 01

Capture

Guided eye and skin scan with quality checks for framing, blur, glare, and lighting.

Step 02

Infer

NoDraw AI models convert optical signals into blood-marker estimates and trend signatures.

Step 03

Route

Confidence-scored outputs feed review queues, escalation pathways, and clinical dashboards.

Blood markers in scope

Current bloodless inference focus includes well-known core blood diagnostics:

HemoglobinRBC countWBC countHematocritPlatelet countMCVMCH
NoDraw app screen for selecting conjunctiva, sclera, or pupillometry capture mode.

Clinical pathway deployment

PathwayTherapy ExamplesFocus
GLP-1 / DiabetesOzempic, Mounjaro, WegovyLongitudinal metabolic monitoring
Chronic LiverRezdiffra, Vemlidy, EpclusaTrend shifts and proactive review
CKD / CardiorenalKerendia, Jardiance, EntrestoRisk and progression tracking
Immunology / OncologyKeytruda, Opdivo, NeulastaCare-team workflow visibility
Technical FlowClinical Evidence

Next Step

Validate NoDraw in your program

Run a technical discovery for biomarker scope, workflow design, governance boundaries, and pilot success metrics.

Book Enterprise PilotContact Team